Stakeholder views of the integration of community pharmacy and primary health care teams
Keywords:
Community pharmacist; primary care physician; primary health care team; integration; qualitative researchAbstract
Introduction: Due to the lack of integration of community pharmacy and primary health care teams a study was designed to explore the views of stakeholders in the Basque health care system (Osakidetza) on the integration of community pharmacy and primary healthcare teams.
Method: A qualitative study, using focus group technique was used. The group met in the Gros health care center (IHO Donostialdea). There were 6 participants from the Basque primary health care system and 2 from community pharmacy. The whole focus group process followed the “Standards for Reporting Qualitative Research (SRQR”) and data generated was thematic content analysis.
Results: The group identified the inherent strengths of community pharmacy as accessibility, geographical distribution and frequency of visits by patients. Pharmacy was seen as a resource that was not optimally used. Despite the philosophical dilemma posed by the integration of a private (community pharmacy) and public (salaried health care professionals) sector, there was seen a need for interprofessional collaboration, via functional integration due to the complexities and length of time required. The starting point was identified as existing relatively small local programs with specific objectives and measurable outcomes that increase communication and build mutual confidence. The content analysis indicated a number of barriers and identified potential stakeholders that should codesign any future potential integration program.
Conclusions: There was general support for the integration of community pharmacy in the primary care system however this was tempered with significant barriers which would suggest a lengthy and complex process.
Downloads
References
Consejo General de Farmacéuticos. Declaración de Córdoba. 23 de octubre de 2014. https://www.portalfarma.com/jornadas-congresos/XIX-Congreso-Nacional-Farmaceutico/Paginas/Declaracion-Cordoba.aspx (Acceso Diciembre, 2020)
Martínez-Martínez F, García-Cárdenas V, Gastelurrutia MA, Benrimoj SI. Barómetro de la Farmacia Comunitaria Española, 2016. Madrid: Ed. Unidad Editorial Revistas; 2017.
Hwang AY, Gums TH, Gums JG. The benefits of physician-pharmacist collaboration. J Fam Pract. 2017 Dec;66(12): E1-E8. PMID: 29202145.
II Congreso SEMERGEN-SEFAC. La importancia de la suma médico-farmacéutico para hallar soluciones en salud https://www.apoyatusalud.com/suma-medico-farmaceutico-soluciones-en-salud/ (Acceso Diciembre, 2020)
Bradley F, Ashcroft DM, Noyce PR. Integration and differentiation: a conceptual model of general practitioner and community pharmacist collaboration. Res Social Adm Pharm. 2012;8(1):36-46. doi:10.1016/j.sapharm.2010.12.005
O'Brien BC, Harris IB, Beckman TJ, Reed DA, Cook DA. Standards for reporting qualitative research: a synthesis of recommendations. Acad Med. 2014; 89(9): 1245-51. doi: 10.1097/ACM.0000000000000388.
Green J, Willis K, Hughes E, Small R, Welch N, Gibbs L, et al. Generating best evidence from qualitative research: the role of data analysis. Aust NZ J Public Health. 2007 Dec;31(6):545-50. doi: 10.1111/j.1753-6405.2007.00141.x.
Stewart DW, Shamdasani PN, Rook DW. Focus Group. Theory and practice. Applied Social Research Methods Series. Volume 20. Thousand Oaks, California (USA): Sage Publications; 2007. ISBN: 0-7619-2583-x
Gastelurrutia MA, Benrimoj SI, Goyenechea E, Martínez-Martínez F. Exploración de las opiniones de agentes implicados sobre la integración entre la farmacia comunitaria y los equipos de Atención Primaria. Aten Primaria. 2021 Mar 31;53(6):102049. Spanish. doi: 10.1016/j.aprim.2021.102049.
Polanco NT, Zabalegui IB, Irazusta IP, Solinís RN, Del Río Cámara M. Building integrated care systems: a case study of Bidasoa Integrated Health Organisation. Int J Integr Care. 2015 Jun 24;15:e026. doi: 10.5334/ijic.1796
Oñatibia-Astibia A, Larrañaga B, Iribar J, Etxebarria A, Odriozola N, Gastelurrutia MA, Bustinduy A, Goyenechea E. A communication protocol between community pharmacists and primary care professionals to solve patients´ medication problems. Int J Integr Care. 2019 19(S1): A99, pp. 1-8 DOI: dx.doi.org/10.5334/ijic.s3099
Aizpurua Arruti X, Malet Larrea A, Oñatibia Astibia A, Martiarena Ayestaran A, Goyenechea Soto E, Gastelurrutia Garralda M.A, Erlauntza: Alianza por la salud comunitaria. Comunicación tipo póster al XI Congreso Nacional de Atención Farmacéutica Cádiz, octubre de 2019.
Varvasovszky Z, Brugha R. A stakeholder analysis. Health Policy Plan 2000;15: 338–345
Sabater-Hernandez D, Tudball J, Ferguson C, Franco-Trigo L, Hossain LN, Benrimoj SI. A stakeholder co-design approach for developing a community pharmacy service to enhance screening and management of atrial fibrillation. BMC Health Serv Res. (2018) 18: 145 https://doi.org/10.1186/s12913-018-2947-7
SEFAP. Cartera de servicios del farmacéutico de atención primaria. Madrid: SEFAP;2017 https://www.sefap.org/wpcontent/uploads/2018/01/Cartera-Servicios-FAP-Final.pdf (Acceso, diciembre, 2020)
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Miguel Ángel Gastelurrutia, Goyenexhea E, Garcia-Cárdenas V, Aizpurua X, Aizpurua X, Martínez-Martínez F
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
La revista Pharmaceutical Care España se publica bajo una licencia «Creative Commons, Reconocimiento, No Comercial y Compartir Igual 4.0 Internacional» (CC BY-NC-SA 4.0)», que permite a otros compartir el trabajo con un reconocimiento de la autoría del trabajo y la publicación inicial en esta revista (con excepción de los usos comerciales).
Los autores que publican en esta revista están de acuerdo con los siguientes términos:a) Los autores conservan los derechos de autor (derechos morales) y garantizan a la revista el derecho de ser el primer soporte documental publicado del trabajo.
b) Se permite y anima a los autores a difundir la versión del trabajo revisado por pares y aceptada para su publicación (por ejemplo, en repositorios institucionales o temáticos), recomendando hacerlo con la versión final del editor “pdf”, “html” o “xml”).
